Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
作者信息
Naber K, Kees F, Denk K, Bauernfeind A, Grobecker H
机构信息
Urologic Clinic, Elisabeth Krankenhaus Straubing, Munich, Federal Republic of Germany.
出版信息
Chemioterapia. 1987 Jun;6(2 Suppl):517-8.
PMID:3334613
Abstract
摘要
相似文献
1
2
Carumonam in the treatment of severe and complicated urinary tract infections.卡芦莫南治疗严重及复杂性尿路感染
Chemioterapia. 1987 Jun;6(2 Suppl):514-5.
3
Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.卡芦莫南与头孢替安治疗复杂性尿路感染的随机研究
Chemioterapia. 1987 Jun;6(2 Suppl):515-6.
4
Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.Ro 17-2301（AMA-1080）与阿米卡星治疗复杂性尿路感染的对比研究。
Chemioterapia. 1987 Jun;6(2 Suppl):519-21.
5
In vitro and in vivo experience with carumonam: a preliminary report.卡芦莫南的体外和体内实验：初步报告。
J Chemother. 1989 Jul;1(4 Suppl):125.
6
Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
Chemioterapia. 1986 Oct;5(5):319-21.
7
Carumonam versus ceftazidime for urinary tract infections.卡芦莫南与头孢他啶治疗尿路感染的比较。
Antimicrob Agents Chemother. 1988 Jul;32(7):1031-3. doi: 10.1128/AAC.32.7.1031.
8
[Aztreonam: monocenter microbiological study with prevention experience in surgery].氨曲南：一项具有外科预防经验的单中心微生物学研究
G Batteriol Virol Immunol. 1987 Jan-Dec;80(1-12):237-51.
9
[Evaluation of the therapeutic effects of aztreonam and ceftazidime in the treatment of complicated infections of the urinary tract].氨曲南和头孢他啶治疗复杂性尿路感染的疗效评估
G Ital Chemioter. 1985 May-Aug;32(2):443-7.
10
Zotero 插件